Evotec SE (0IRF)
LSE
Real-time Data
07:00 AM
Day's Range
3.2752 wk Range
2.88Overview - 0IRF - Evotec SE
Key Statistics
Valuation
Enterprise Value
2.91B
P/E (Trailing)
‪-5.68‬
PEG Ratio
‪-0.01‬
Price / Sales (TTM)
‪0.81‬
Price / Book
‪0.50‬
EV / EBITDA
‪25.89‬
Profitability
Gross Margin
‪-1.00%‬
Profit Margin
‪-12.93%‬
Operating Margin
‪5.54%‬
Return on Assets
‪1.20%‬
Return on Equity
‪-8.43%‬
Ownership
Shares Outstanding
177.59M
Float
143.22M
Held by Insiders
‪9.22%‬
Held by Institutions
‪54.71%‬
Price stats
Beta
‪1.08‬
50-Day Avg
‪4.08‬
200-Day Avg
‪5.03‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 0IRF - Evotec SE
Peers - 0IRF - Evotec SE
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0IRFLSEEvotec SE648.20MMarket Cap-82.29%52-week change-5.75P/E (Trailing)‪-12.93%‬Profit Margin
- HLNLSEHaleon plc3.25TMarket Cap+3.25%52-week change20.17P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change18.82P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc340.01BMarket Cap+1.45%52-week change—P/E (Trailing)‪-10.78%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB163.60BMarket Cap+35.36%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited154.69BMarket Cap-27.81%52-week change184.00P/E (Trailing)‪3.25%‬Profit Margin
- 0O14LSEMerck KGaA64.01BMarket Cap+20.52%52-week change19.49P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0IRF - Evotec SE
About
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrated drug discovery solutions on a fee-for-service basis or via…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
